1590. Updated Aminoglycoside (AG) MIC Breakpoints (BP) to Minimize Adverse Events and Improve Outcome: Impact on Susceptibility (S) Rates

BACKGROUND: In 2016 USCAST, the National Advisory Committee (NAC) for the United States (US) to EUCAST, undertook the re-evaluation of the in vitro susceptibility (AST) test interpretive criteria (IC) for gentamicin (GM), tobramycin (TO) and amikacin (AK) against Enterobacteriaceae (ENT), P. aerugin...

Descripción completa

Detalles Bibliográficos
Autores principales: Pfaller, Michael A, Flamm, Robert K, Ambrose, Paul G, Andes, David, Bradley, John S, Bhavnani, Sujata M, Jones, Ronald N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809765/
http://dx.doi.org/10.1093/ofid/ofz360.1454

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809765/
http://dx.doi.org/10.1093/ofid/ofz360.1454

Ejemplares similares